In a recently published study, PC has contributed its bacteriophage expertise to promising research highlighting potential use of phage proteins as building blocks for nanoscale protein materials, which can in turn be used as drug or vaccine carriers of clinical importance.
Click here to find out more @ Pharmaceutical Networking
Or read the article here: Engineering Protein Nanoparticles Out from Components of the Human Microbiome